Hippocratic AI
Hippocratic AI Raises $126 million in Series C
Hippocratic AI Raises $126 million in Series C
Hippocratic AI has successfully raised $126 million in a Series C at a $3.5 billion valuation led by Avenir Growth.
Company Overview
Hippocratic AI is a HealthTech company headquartered in Palo Alto CA, founded in 2023 with 300+ employees.
Hippocratic AI builds non-diagnostic patient-facing clinical AI agents for healthcare. In 15 months since commercialization the company established partnerships with over 50 large health systems payors and pharma clients in 6 countries built over 1000 clinical use cases and completed over 115 million clinical patient interactions.
Fundraising Details
- Amount Raised: $126 million
- Round Type: Series C
- Valuation: $3.5 billion valuation
- Date: 2025-11-03
- Investors: Avenir Growth and CapitalG and General Catalyst and Andreessen Horowitz and Kleiner Perkins and Premji Invest
About Hippocratic AI
Hippocratic AI builds non-diagnostic patient-facing clinical AI agents for healthcare. In 15 months since commercialization the company established partnerships with over 50 large health systems payors and pharma clients in 6 countries built over 1000 clinical use cases and completed over 115 million clinical patient interactions. The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Palo Alto CA
- Founded: 2023
- Team Size: 300+
- Industry: HealthTech
What This Means
This funding round demonstrates strong investor confidence in Hippocratic AI's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Hippocratic AI's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching $3.5 billion valuation marks an important milestone for Hippocratic AI, positioning the company among notable players in the HealthTech industry.
Looking Ahead
With this new capital, Hippocratic AI is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2025-11-03. For more information about Hippocratic AI, visit their headquarters at Palo Alto CA.
Company Info
Investors (6)
Share
Related Reports
Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform
Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.
Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation
French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.
AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment
Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free